about
Administration of supplemental L-tyrosine with phenelzine: a clinical literature reviewManagement of L-dopa overdose in the competitive inhibition state.5-HTP efficacy and contraindications.Relative nutritional deficiencies associated with centrally acting monoaminesParkinson's disease managing reversible neurodegeneration.The discrediting of the monoamine hypothesis.Parkinson's disease: carbidopa, nausea, and dyskinesia.
P2860
Q26853627-DAE7DB33-C76D-4653-993F-773AA22F0787Q33961000-BF253761-2B11-457C-B61F-427F4CAC70B6Q34033104-BED44350-19A0-4CF8-AE75-E369A2F47E4DQ35971066-AFF88B7C-4875-4850-8333-D9FE49506C27Q40030359-89D520F3-386D-4B45-93D5-5B8A104A386BQ41293852-FF863625-175A-4516-97BA-D21E91D55C8AQ41780193-A1A67FBD-2E34-40F9-AC27-B71C7D47F47E
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Monoamine depletion by reuptake inhibitors.
@ast
Monoamine depletion by reuptake inhibitors.
@en
type
label
Monoamine depletion by reuptake inhibitors.
@ast
Monoamine depletion by reuptake inhibitors.
@en
prefLabel
Monoamine depletion by reuptake inhibitors.
@ast
Monoamine depletion by reuptake inhibitors.
@en
P2093
P2860
P356
P1476
Monoamine depletion by reuptake inhibitors.
@en
P2093
Alvin Stein
Marty Hinz
Thomas Uncini
P2860
P356
10.2147/DHPS.S24798
P407
P577
2011-10-20T00:00:00Z